Tumor products and the hypercalcemia of malignancy.
作者信息
Mundy G R, Ibbotson K J, D'Souza S M
出版信息
J Clin Invest. 1985 Aug;76(2):391-4. doi: 10.1172/JCI111984.
Abstract
摘要
相似文献
1
Tumor products and the hypercalcemia of malignancy.肿瘤产物与恶性肿瘤高钙血症
J Clin Invest. 1985 Aug;76(2):391-4. doi: 10.1172/JCI111984.
2
The hypercalcemia of cancer. Clinical implications and pathogenic mechanisms.癌症相关性高钙血症。临床意义及发病机制。
N Engl J Med. 1984 Jun 28;310(26):1718-27. doi: 10.1056/NEJM198406283102607.
3
Hypercalcemia of malignancy: the central role of parathyroid hormone-related protein.恶性肿瘤高钙血症：甲状旁腺激素相关蛋白的核心作用
Annu Rev Med. 1994;45:189-200. doi: 10.1146/annurev.med.45.1.189.
4
Parathyroid hormone-related peptide and hypercalcemia of malignancy.甲状旁腺激素相关肽与恶性肿瘤高钙血症
Cancer Treat Res. 1997;89:193-215. doi: 10.1007/978-1-4615-6355-6_10.
5
[Tumor hypercalcemia].[肿瘤相关性高钙血症]
Rev Clin Esp. 1985 Nov;177(8):361-3.
6
Role of parathyroid hormone-related peptide in hypercalcemia of malignancy and the development of osteolytic metastases.甲状旁腺激素相关肽在恶性肿瘤高钙血症及溶骨性转移发生中的作用
Rev Rhum Engl Ed. 1997 Jun 30;64(6 Suppl):119S-123S.
7
[Metabolic bone diseases: malignancy-associated hypercalcemia].[代谢性骨病：恶性肿瘤相关性高钙血症]
Nihon Rinsho. 1986 Nov;44(11):2467-72.
8
Hypercalcemic factors other than parathyroid hormone-related protein.除甲状旁腺激素相关蛋白之外的高钙血症因子。
Endocrinol Metab Clin North Am. 1989 Sep;18(3):795-806.
9
Treatment of hypercalcemia associated with malignancy.与恶性肿瘤相关的高钙血症的治疗。
Semin Oncol. 1978 Jun;5(2):141-53.
10
[Malignancy-associated hypercalcemia].[恶性肿瘤相关性高钙血症]
Nihon Naika Gakkai Zasshi. 1995 May 10;84(5):808-12.
引用本文的文献
1
Parathyroid Hormone-related Protein in Breast Cancer Tissues: Relationship between Primary and Metastatic Sites.乳腺癌组织中的甲状旁腺激素相关蛋白：原发部位与转移部位之间的关系
Breast Cancer. 1994 Jul 30;1(1):43-49. doi: 10.1007/BF02967374.
2
Measurement of urinary collagen cross-links indicate response to therapy in patients with breast cancer and bone metastases.尿中胶原交联物的测量表明乳腺癌和骨转移患者对治疗的反应。
Br J Cancer. 1999 Jun;80(8):1265-70. doi: 10.1038/sj.bjc.6690496.
3
Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.中国人群住院高钙血症患者调查中甲状旁腺激素和甲状旁腺激素相关蛋白检测
J Endocrinol Invest. 1997 Jul-Aug;20(7):404-9. doi: 10.1007/BF03347992.
4
A case of renal cell carcinoma with metastasis to the thyroid gland and concomitant early gastric cancer.一例肾细胞癌转移至甲状腺并伴有早期胃癌。
Surg Today. 1993;23(2):153-8. doi: 10.1007/BF00311234.
5
The expression of parathyroid hormone-related protein in human breast cancer with skeletal metastases.甲状旁腺激素相关蛋白在伴骨转移的人乳腺癌中的表达
Surg Today. 1994;24(3):215-20. doi: 10.1007/BF02032890.
6
Chronic intramedullary infusion of interleukin-1 alpha increases bone mineral content in rats.长期骨髓内注射白细胞介素-1α可增加大鼠的骨矿物质含量。
Calcif Tissue Int. 1994 Aug;55(2):103-8. doi: 10.1007/BF00297184.
7
Malignant hypercalcaemia.恶性高钙血症
Br Med J (Clin Res Ed). 1985 Oct 12;291(6501):1049. doi: 10.1136/bmj.291.6501.1049-c.
8
Skeletal effects of carcinoma of the breast and prostate.乳腺癌和前列腺癌的骨骼影响。
Ann R Coll Surg Engl. 1986 Sep;68(5):267-70.
9
Quantitation of the renal effect of calcitonin in the hypercalcaemia of malignancy.降钙素对恶性肿瘤高钙血症肾脏影响的定量研究
Eur J Clin Pharmacol. 1986;31(1):27-31. doi: 10.1007/BF00870981.
10
3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancer.3-（氨基-1,1-羟基亚丙基）双膦酸盐（APD）治疗乳腺癌高钙血症。
Br J Cancer. 1987 Oct;56(4):465-9. doi: 10.1038/bjc.1987.225.
本文引用的文献
1
Relation of osteoclast activating factor production to extent of bone disease in multiple myeloma.破骨细胞激活因子产生与多发性骨髓瘤骨病程度的关系。
Br J Haematol. 1981 Jan;47(1):21-30. doi: 10.1111/j.1365-2141.1981.tb02758.x.
2
Autocrine secretion and malignant transformation of cells.细胞的自分泌分泌与恶性转化。
N Engl J Med. 1980 Oct 9;303(15):878-80. doi: 10.1056/NEJM198010093031511.
3
Hypophosphatemic osteomalacia: association with prostatic carcinoma.低磷性骨软化症：与前列腺癌的关联。
Ann Intern Med. 1980 Aug;93(2):275-8. doi: 10.7326/0003-4819-93-2-275.
4
Collagen and collagen-derived fragments are chemotactic for tumor cells.胶原蛋白及胶原蛋白衍生片段对肿瘤细胞具有趋化作用。
J Clin Invest. 1981 Oct;68(4):1102-5. doi: 10.1172/jci110334.
5
Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: uncoupling of bone cell activity.恶性肿瘤体液性高钙血症的定量骨组织形态计量学：骨细胞活性的解偶联
J Clin Endocrinol Metab. 1982 Aug;55(2):219-27. doi: 10.1210/jcem-55-2-219.
6
Absence of parathyroid hormone messenger RNA in nonparathyroid tumors associated with hypercalcemia.与高钙血症相关的非甲状旁腺肿瘤中甲状旁腺激素信使核糖核酸的缺失。
N Engl J Med. 1983 Aug 11;309(6):325-30. doi: 10.1056/NEJM198308113090601.
7
Inhibition of parathormone-stimulated bone resorption by type I interferon.I型干扰素对甲状旁腺激素刺激的骨吸收的抑制作用。
Biochem Biophys Res Commun. 1984 Apr 30;120(2):553-8. doi: 10.1016/0006-291x(84)91290-7.
8
Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis.结节病中培养的肺泡巨噬细胞对25-羟基维生素D3的代谢
J Clin Invest. 1983 Nov;72(5):1856-60. doi: 10.1172/JCI111147.
9
Factors associated with humoral hypercalcemia of malignancy stimulate adenylate cyclase in osteoblastic cells.与恶性肿瘤体液性高钙血症相关的因素可刺激成骨细胞中的腺苷酸环化酶。
J Clin Invest. 1983 Oct;72(4):1511-5. doi: 10.1172/JCI111108.
10
DNA synthesis is not necessary for osteoclastic responses to parathyroid hormone in cultured fetal rat long bones.在培养的胎鼠长骨中，破骨细胞对甲状旁腺激素的反应并不需要DNA合成。
J Clin Invest. 1983 Dec;72(6):1924-9. doi: 10.1172/JCI111156.
Zotero 插件